Stay updated on Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.
Latest updates to the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference0.9%
- Check15 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.9%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check36 days agoNo Change Detected
- Check50 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.1%
- Check72 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.4%
- Check79 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
Stay in the know with updates to Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.